October 6, 2023

How can you harness the potential of nucleic acid therapeutics?

At Cytiva, the new team is here to support you. We can help you throughout the
development of your manufacturing workflow for oligonucleotides
and the purification of mRNA drug substances. And, in
collaboration with our colleagues at Precision Nanosystems,
we’ll help you bring mRNA lipid nanoparticle therapeutics to market.
There’s a lot of work to do. Let’s get going.

Tags: Nucleic acid therapeutics Oligonucleotide Oligos mRNA mRNA variants oligo-based therapeutics